Christopher Benz, MD, Oncology, San Francisco, CA, Zuckerberg San Francisco General Hospital and Trauma Center

ChristopherC.BenzMD

Oncology San Francisco, CA

Hematologic Oncology

Physician

Dr. Benz is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Benz's full profile

Already have an account?

Education & Training

  • University of Michigan Medical School
    University of Michigan Medical SchoolMEDICAL_SCHOOL

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1981 - 2001
  • CA State Medical License
    CA State Medical License 1973 - 2022
  • WA State Medical License
    WA State Medical License 1973 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Elected Member The American Society for Clinical Investigation, 1991

Publications & Presentations

PubMed

Press Mentions

  • Largest Cancer Genomics Study Spurs Efforts to Promote Specialized Clinical Trials
    Largest Cancer Genomics Study Spurs Efforts to Promote Specialized Clinical TrialsApril 08, 2018 11:25
  • New Comprehensive Analysis of Breast and Gynecological Cancers
    New Comprehensive Analysis of Breast and Gynecological CancersApril 06, 2018 11:11
  • Major Project Completes Genetic 'Map' of 33 Cancers
    Major Project Completes Genetic 'Map' of 33 CancersApril 06, 2018 11:11
  • Join now to see all

Grant Support

  • Mass Spectrometry To Decode PTM Patterns And Enhance The Biomarker Utility Of ERNational Cancer Institute2010–2012
  • Polyribosome Targets Mediating MRNA Decay For Cancer Prediction And TherapyNational Cancer Institute2011
  • Ucsc-Buck Inst. Genome Data Analysis Center For TCGA Research Network (GDAC)National Cancer Institute2009–2011
  • Clinical Significance Of Functionally Defective Estrogen ReceptorNational Center For Research Resources2006–2008
  • Defective Estrogen Receptors In Breast TumorsNational Cancer Institute2000–2008
  • Biology Of Breast Cancers Arising In Older WomenNational Institute On Aging2003–2007
  • Therapeutic Modulation Of Breast Cancer OncogenesNational Cancer Institute2000–2007
  • Ecological &Clin Sig Of Defective Estrogen Receptor From Human Breast TumorNational Center For Research Resources2005
  • Ecological &Clin Sig Of Defective Estrogen ReceptorNational Center For Research Resources2004
  • Developmental Research Program--Breast CancerNational Cancer Institute1995–2002
  • Development Of Membrane Receptor Targeted And Tumoricidal Breast Cancer TherapyNational Cancer Institute1995–2002
  • Defective Estrogen Receptors In Breast TumorsNational Cancer Institute1999–2000
  • Activation Of Oncogenes And Receptors In Human Breast Cancer--Ets And Her2/NeuNational Cancer Institute1996–2000
  • Therapeutic Modulation Of Breast Cancer OncogenesNational Cancer Institute1995–2000
  • Antierbb2 Antibody Induced Protein InteractionsFogarty International Center1999
  • Defective Estrogen Receptors In Human Breast TumorsNational Cancer Institute1996–1998
  • Activation Of Oncogenes And Receptors In Human Breast Cancer--Ets And Her2/NeuNational Cancer Institute1995–1998
  • Therapeutic Modulation Breast Cancer Oncogenes, EstrogenNational Cancer Institute1994
  • Activation Of Oncogenes And Receptors In Breast CancerNational Cancer Institute1991–1994
  • Therapeutic Modulation Of Breast Cancer Oncogenes &EstrNational Cancer Institute1991–1993
  • Modulation Of Receptor Signal Trandsuction.....National Cancer Institute1992
  • Activation Of Oncogenes And Receptors In Breast CancerNational Cancer Institute1990
  • Investigations Into Selectivity And Monitoring SystemsNational Cancer Institute1988–1990
  • Antiestrogen/5-Fu Drug Combinations In Breast CancerNational Cancer Institute1987–1990
  • Transforming Genes Expression In Breast CancerNational Cancer Institute1989
  • Steroids And Antimetabolites In Pancreatic CarcinomaNational Cancer Institute1985–1986
  • 5-Fluorouracil And Antiestrogens In Breast CancerNational Cancer Institute1985–1986

Hospital Affiliations